Show items per page
Elements: 5
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... Gabay, Cem 2012
add to browser selection
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... van Vollenhoven, Ronald F 2016
add to browser selection
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs Smolen, Josef S.; Landewe, Robert; Breedveld, Ferdinand C.; Dougados, Maxime; ... van der Heijde, D. 2010
add to browser selection
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... van Vollenhoven, Ronald F 2011
add to browser selection
Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration Chatzidionysiou, Katerina; Lie, Elisabeth; Lukina, Galina; Hetland, Merete L; ... van Vollenhoven, Ronald 2017